Cytel Is A Global Leader In Clinical Trial Design Softwarebiometric Servicesand Advanced Analyticsheadquartered In Walthammassachusettsas A Clinical Research Organizationcro Cytel Focuses On Optimizing Clinical Trials And Assisting Pharmaceutical Companies In Leveraging Their Clinical And Real World Data Effectively The Company Offers A Comprehensive Suite Of Services Tailored To The Needs Of Biotech Firms Throughout The Drug Development Processthis Includes Clinical Trial Design And Simulation Through Its East Horizon Platformwhich Utilizes Adaptive And Bayesian Toolscytel Also Provides Advanced Analytics And Biometric Servicesalong With Solutions That Incorporate Real World Data To Support Drug Development And Post Market Surveillance Cytel Has A Strong Presence In The Industryworking With Pharmaceutical And Biotech Companies Worldwidein 2024The Company Reported A Revenue Of Eur 290 Million And Employs Around 1 560 Peoplecytel Is Committed To Sustainabilitywith Its Greenhouse Gas Emissions Reduction Targets Validated By The Science Based Targets Initiative
